Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural configuration enables selective binding to specific enzyme active sites, enhancing drug efficacy and reducing off-target effects. Commonly employed in the production of investigational oncology drugs where stereochemical purity is critical for biological activity. Also utilized in the preparation of serotonin receptor modulators due to its affinity for central nervous system targets. Its hydrochloride salt form improves solubility and stability during formulation processes.